Company Number: 14616925

Analysis Date: 2025-07-29 20:09 UTC

Financial Health Assessment: PRIMA & PHILANA LTD (As at 31 January 2024)

---

1. Financial Health Score: B

Explanation:
PRIMA & PHILANA LTD shows a solid start-up financial position with positive net assets and healthy working capital. The company has no audit requirement due to its small size and has complied with filing obligations on time. The "B" grade reflects a generally good financial condition typical for a young micro-entity, with room for growth and optimization, particularly in cash management and revenue generation.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Current Assets	24,947	Healthy short-term resources, mostly cash
Cash and Cash Equivalents	23,039	Strong liquidity for immediate expenses
Debtors (Receivables)	1,908	Moderate amount tied up in customer payments
Current Liabilities	5,154	Manageable short-term obligations
Net Current Assets (Working Capital)	19,793	Indicates good short-term financial health
Net Assets (Equity)	19,793	Positive equity base, no debt reported
Share Capital	100	Nominal capital invested by shareholders
Profit & Loss Reserve	19,693	Retained earnings suggest initial profitability
Employees	1	Micro business scale

---

3. Diagnosis

• Healthy Cash Flow: The company holds a robust cash balance (£23,039), which is a vital sign indicating good liquidity. This is critical for meeting day-to-day expenses without stress.
• Stable Working Capital: With net current assets of nearly £20k, the business has sufficient short-term assets to cover liabilities, suggesting no immediate liquidity crisis.
• Positive Equity: Net assets equal shareholders’ funds, meaning the company is not reliant on debt financing, a healthy indicator for a start-up.
• Low Operational Scale: The micro size, with one employee and modest debtor levels, indicates the company is in early stages of operation or niche activity.
• Compliance and Governance: Timely filing of accounts and returns without overdue status reflects good administrative health, reducing regulatory risk.
• Profitability Indicators: The profit and loss reserve nearly matches net assets, indicating the company has generated some retained profit during its first year.

Symptoms of Potential Concern:

• The company’s turnover and profitability data are not explicitly stated, so revenue growth and margin sustainability cannot be fully assessed.
• Dependence on a single director/shareholder could pose governance risks.
• Industry classification (Other human health activities) often requires compliance with regulatory standards, which may increase operational costs.

---

4. Recommendations

• Enhance Revenue Tracking: Begin detailed monitoring of turnover and profit margins to identify growth opportunities and cost controls.
• Maintain Strong Liquidity: Continue prudent cash management to ensure healthy cash flow, especially as the business scales.
• Diversify Stakeholder Base: Consider appointing additional directors or advisors to strengthen governance and strategic oversight.
• Plan for Growth: Develop a business plan focusing on customer acquisition and service expansion, leveraging the current healthy financial base.
• Regulatory Compliance: Stay vigilant regarding health sector regulations to avoid penalties or operational interruptions.
• Financial Reporting: As the business grows, consider moving beyond exemption thresholds to audited accounts for increased transparency and credibility with stakeholders.

---